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Abstract 
 
Background: The aim of the study was to understand the characteristics of the International 
Federation of Psycho-Oncology Societies (FPOS) and possible disparities in providing 
psychosocial care in countries where psycho-oncology societies exist. 
Method: A survey was conducted among 29 leaders of 28 countries represented within the 
FPOS by using a questionnaire covering (i) characteristics of the society; (ii) characteristics of 
the national health care system (NHS); (iii) level of implementation of psycho-oncology and 
(iv) main problems of psycho-oncology in the country.  
Results: Twenty-six (90%) FPOS returned the questionnaires. One-third reported to have 
links with and support from their government, while almost all had links with other scientific 
societies. FPOS varied in their composition of members’ professions. Psychosocial care 
provision was covered by state-funded health services in a minority of countries. Disparities 
between countries arose from different causes and were problematic in some parts of the 
world (e.g. Africa, SE Asia). Elsewhere (e.g. Southern Europe, Eastern Europe), austerity 
policies were reportedly responsible for resource shortages with negative consequences on 
psychosocial cancer care. Half of FPOS rated themselves to be integrated into mainstream 
provision of care, although lack of funding was the most common complain.  
Conclusion:  The development and  implementation of psycho-oncology  is fragmented and 
undeveloped, particularly in some parts of the world.  More effort is needed at national level 
by strong coalitions with oncology societies, better national research initiatives, cancer plans 
and patient advocacy, as well as by stronger partnership with international organizations (e.g. 
WHO, UICC). 
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Introduction 
 
Cancer is a worldwide problem and globally attention has been directed by national 
governmental organizations and health institutions to emphasize policies of prevention and 
screening, treatment, follow-up, and palliative care [1,2,3].  However, internationally, social 
inequalities persist in terms of cancer care, especially, but not only, in socioeconomically 
disadvantaged groups, under-served communities and in developing countries. [4] As regards 
psychosocial care at least 30% of cancer patients report psychosocial distress and mental 
disorders [5] and a even higher percentage report unrecognized psychosocial needs or 
untreated psychosocial disorders as a consequence of cancer at some point during the cancer 
trajectory. [6,7]  For example, while point prevalence rates of 40% are commonly reported, 
only in around one-in-six [8] to one-in-twelve [9)] women with breast cancer do these 
problems persist, sometimes over many years, often linked to unresolved symptoms such as 
pain [10]. The literature consistently indicates that persistent psychosocial conditions have 
extremely negative consequences for the patients, including poorer quality of life [10] and 
shorter survival [11,12]  
Consequently there is an urgent need to ensure appropriate psychosocial care is available in 
cancer settings. However, as with other cancer services, inequalities exist. As reported by 
Koch [13], although a large number of evidence-based studies have demonstrated the benefit 
from structured psychosocial care services in oncology, with a growing consensus on the 
mandatory integration of psychosocial care into the routine care of cancer patients [14], there 
is an evident lack of precise and comprehensive information about psycho-oncology services 
within the national health-care systems of different countries. This lack of information 
pertains to several aspects of care, such as if and where psychosocial services in different 
health-care provision areas of cancer care are available (e.g. inpatient and outpatient services, 
rehabilitation, and palliative care), what type of professionals of different disciplines (and 
their qualifications) work in psychosocial oncology services, and how much these services are 
integrated in the existent oncological services. According to Keller et al. [15], some of the 
main indicators of psychosocial oncology are not followed by most of the countries where the 
objectives and the topics of psychosocial health-care research for cancer patients, the study of 
structural conditions of psycho-oncology services and of psycho-oncology interventions 
under routine conditions, and quality assurance are lacking.  
 5 
In Europe, a recent survey conducted under the European Partnership on Action Against 
Cancer [EPAAC] and involving 27 representatives of European countries, showed that only 
eight (30%) reported having nationally recommended psychosocial oncology care (PSOC) 
clinical guidelines, with ten (37%) having specific budgets for PSOC, and six (22%) having 
an official certification for PSOC education. [16] 
The situation is even more fragmented and diverse when considered internationally. In one of 
the first surveys conducted by interviewing 45 psycho-oncology experts from 38 countries 
[17], it was shown that psychosocial oncology was not fully integrated into oncological care 
in the majority of the countries from which experts responded. In at least one-third of the 
countries psychosocial oncology was not widely known or only accepted within educated and 
well-informed subgroups, and in the same percentage there was a lack of knowledge about the 
need or benefits psychosocial care. A series of different barriers were identified, including 
financial constraints, that were mentioned by almost all of the experts who responded, poor 
transfer of psychosocial research results into clinical practice, lack of knowledge and 
acceptance by medical professionals, stigmatization from being labeled as having a 
psychiatric problem or as being unable to cope with the disease, poor understanding of 
psychosocial support by cancer patients, and reticent trends towards disclosure of cancer 
diagnosis were slow, were still as  problems in some countries.  
Where Psycho-Oncology Societies (POS) have existed for many years, however, the situation 
of psychosocial oncology care in those countries is expected to be and should be more 
structured and defined. The mission of POS in fact is usually not only to promote 
psychosocial care of cancer patients and their families through the development of standards, 
practice guidelines, and service integration strategies, but also to foster interprofessional and 
political (e.g. administrators, policy makers and other stakeholders) collaboration in 
psychosocial oncology care. When the IPOS Federation of Psycho-Oncology Societies 
(FPOS) was founded  in 2008, [18] the opportunity has been offered to begin to explore this 
specific area and to understand the situation in the countries where a scientific society exists 
is more advanced in terms of care and integration within the national health system. In a 
preliminary study carried out within the FPOS, however, the impact of scientific societies was 
found to be not determining, with only a few countries (mainly in Europe),  resulting to have 
national cancer plans underlining (or at least mentioning) the mandatory role of psychosocial 
care in oncology. In contrast, in many others, especially, but not exclusively, in developing 
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nations, psychosocial oncology is either still not established or not completely established, or 
not an integral part of cancer care or not specifically offered except within the context of 
more, general psychological support, even if an established POS was operating [19].  
Given the need to better understand these data and the main problems causing possible 
disparities  in psychosocial oncology care in countries were POS are active, the present study, 
as part of a shared program within the FPOS, aimed at examining the characteristics of the 
POS represented within the Federation, the possible differences in the health care system 
organization of the respective countries,  and the main problems of the single POS in 
disseminating psychosocial care in cancer settings in their own countries. 
 
Methods 
 
At the time of the study the Federation consisted of 28 POS in 29 countries worldwide (Fig 
1). For the aims of this survey the methodology of other similar investigations [17,18,19] was 
followed, by using a short questionnaires with mainly open questions. The  questionnaire of 
employed in this survey was developed on an agreement basis within the representatives of 
the FPOS members at a specific meeting held at the IPOS Congress in Rotterdam in 2012. At 
the meeting the representative members of the FPOS unanimously decided to investigate, in 
his phase, some specific areas in a semi-structured way, leaving for the future a further 
exploration with a more traditional multi-item Likert-scale questionnaire, according to the 
descriptive data that would be emerged in this study. Since the main aim of the questionnaire 
were to assess the profile of each society, the criteria for the developmental level of palliative 
care service from the Global Atlas of Palliative Care [20] was adopted by replacing the word 
palliative care by psychosocial oncology care. The major areas covered by the questionnaire 
are reported in Appendix 1, in which six levels of psychosocial care organization is indicated, 
as reached on a consensus basis within the above-mentioned FPOS meeting.  The president 
(or a designated member) of each POS was then officially approached and the questionnaire 
emailed in January 2014.   
By following what done in similar studies [18,19], since the responses regarded qualitative 
data, only descriptive statistics were used to analyze the questionnaire.   
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Results 
Of 29 POS belonging to the Federation in 2014 and representing 28 countries  (with Portugal 
having 2 national POS), data were available for 25 (89.5%).  
Members and type of profession 
The total membership of the 26 POS was 7,532 (minimum 15, Slovenia, founded in 2011, 
maximum 1,683, Japan, founded in 1986), of whom were 2,552 in Europe, 2,355 in East Asia 
(organized in the East Asian Psycho-Oncology Network, EAPON, now called  Asian Pacific 
Psycho-Oncology network - APPON), 1,257 in Australia/New Zealand, 1,080 in North 
America, 162 in Middle East, and 100 in Africa (Table 1). 
Regarding the primary profession (Fig 2), 30% of the members   were psychologists 
(n=2,317), 29% physicians (n=788 psychiatrists, n=1410 other physicians),  12.5% nurses 
(n=947, of whom 580 were specialized cancer or palliative care nurses and 367 registered 
nurses), 7.8% social workers (n=590), approximately  3% patient/family members (n=50),  
pastoral care persons (n=40), rehabilitators (n=40) and 2% full-time researchers (n=146). 
About 16% members belong to other professions (including physical, sex, or occupational 
therapists; pharmacists) or categories (including  students, administrators, and other allied 
health groups). 
There were differences by continents, with a higher ratio of physicians (including 
psychiatrists) (45-70%) with respect to psychologists (13-28%) and nurses (15-18%) in 
Eastern Asian POS; a higher ratio of psychologists (35-40%) and social workers  (25-30%) 
with respect to physicians (including psychiatrists) (20%) in North America and  in Australia 
/New Zealand; and a higher ratio of psychologists (30-90%) in comparison with physicians 
(including psychiatrists) (30-40%) in European POS, with the highest percentage of 
psychologists being in the Polish and Spanish (80%), and South American POS (90%). 
Health Organization system 
There were major differences among countries regarding the structure and organization of 
health systems and provision of psychosocial care.  In some Northern American and Asian 
countries, including  Canada, Japan, and Taiwan) universal-coverage national health systems 
fund cancer care, including psychosocial aspects; in others, including the USA and China 
when government-funded health system or private insurance does not completely cover all 
citizens, or co-payment is required, patient advocacy organizations and professional 
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organizations in some instances provide psychosocial care having incorporated these services 
as part of comprehensive cancer care.  Otherwise, access may be lacking. 
In several European countries government-based insurance systems, the National Health 
Service (UK) or the national universal healthcare insurance coverage, (for example France 
and Germany) includes psychosocial care, with widespread acknowledgment of the 
importance of psychosocial care throughout the cancer continuum and psycho-oncologists 
integrated in supportive care teams or with strong links with supportive care professionals. In 
other European countries, insufficient insurance coverage for psychological treatment and 
psychosocial care is reported, in part because of the nature of the health care system. In a 
growing number of European countries, economic austerity policies are reducing health care 
spending, forcing cuts to all but most basic services, impacting psycho-oncology and mental 
health in general.   
Elsewhere, for example in African and some SE Asian countries, the availability of 
appropriate primary cancer treatment itself is a problem, with limited access to first-line 
therapies, such as surgery, radiotherapy and chemotherapy, significant urban-rural inequalities 
and economic and geographic barriers and rudimentary National health insurance schemes. 
These problems mean access is mostly only available to a small, often urban-based elite 
portion of the population. This has been reported to contribute to delayed cancer diagnosis in 
numerous patients with negative consequences in terms of prognosis and outcome, 
particularly where chronic disease care has to compete with other care demands such as 
maternal and neonatal care, communicable diseases and violence. Understandably this creates 
problems in screening, early diagnosis and treatment of cancers. In some places, disruption of 
and even targeting of health services by political instability, war or insurgency prohibits even 
the most basic care. 
 
National variation in psycho-oncology service development  
The situation of psychosocial care in oncology, according to the 6 possible levels of 
organization (see Appendix 1), as represented in the country, is detailed in Table 1.  Overall 
23% of the POS indicated in their own country embodied isolated care provision of 
psychosocial oncology (Level 3a); 20% indicated that a generalized care provision (Level 3b); 
46% were in a more advanced state (Level 4a), having preliminary integration into 
mainstream service; only 11% indicated an advanced integration into mainstream service 
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provision (Level 4b). Globally, 50% of POS in Europe, Asia and Australia/New Zealand 
referred to their psycho-oncology situation as level 3 and 50% as Level 4, while 100% in 
North America rated it as Level 4. More problems were found in South America and Africa 
where the only societies existing there rated psycho-oncology as isolated (Level 3a). In 
Africa, one country (that had not formally a society, but in the process of doing that at the 
time of the study) rated the situation as in progress with possible capacity of building 
activities, though no service has yet been established (Level 2).  
 
Main reported problems 
Several types of problems were however reported by the POS participating in the survey 
(Table 3). All POS underlined a lack of financial support for psycho-oncology services. Some 
societies (mainly in Eastern and Southern Europe, Africa and South America) also indicated 
that the austerity had worsened the situation with several negative effects, on, for example, 
stalling the implementation of National Cancer Plans  (psychosocial care integrated into 
cancer care) and not being considered essential to service implementation (e.g. Italy). Several 
societies (e.g. Netherlands) reported the need for more scientific evidence for the cost-
effectiveness of various psychosocial interventions for the patient and for society in order to 
increase the willingness of medical specialists to refer, of health insurance companies to 
reimburse and of the political world to put psychosocial care high on the agenda. 
 
Discussion 
In this study, coordinated under the aegis of IPOS, we reported data from 26 psycho-oncology 
societies, representing 25 countries in the world, that are members of the international 
Federation of POS, representing several countries in the world,  with additional input from 
APPON members.  
As an initial finding, significant differences were found between the organization of the POS, 
in part reflecting the differences in the health organizational systems of the countries that 
were part of the survey. It is in fact difficult to compare POS that have a huge number of 
members and seem extremely well developed with more limited societies struggling with 
needs for recognition within their country and health systems or where the numbers of active 
psycho-oncology workers amount to only a handful. Also the role of professionals is quite 
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different, with some societies consisting almost completely of psychologists, others having a 
high percentage of physicians, mainly but not only psychiatrists, and others involving also 
nurses and social workers. A general trend was apparent confirming what reported in a 
previous Federation survey [19], specifically that of POS are formally linked to institutional 
bodies (e.g. Ministry of health, central governmental institutions) with psycho-oncology fully 
recognized in National Cancer Plans (NCPs).  
In terms of implementation of psycho-oncology and self-evaluation of their status, only a 
minority of POS representatives (1 in Europe, 1 in Asia, 1 in Australia) reported in their own 
country an advanced integration into mainstream service provision, with psychosocial 
oncology care available in a wide range of locations, a comprehensive provision of care by 
multiple service providers, a substantial impact of psychosocial oncology care upon policy, an 
unrestricted availability of multiple aspects of psychosocial oncology care, a broad awareness 
of psychosocial oncology care on the part of health professionals, local communities and 
society in general; as well as a development of recognized education centers and academic 
links forged with universities.in particular upon public health policy.  The situation in Europe, 
in particular, seemed to be fragmented in countries were POS have been long established, 
with more problems in Southern and Eastern European than Northern European countries. In 
those countries, because of restriction of investments and irrespective of the recognition or not 
of psychosocial oncology within the national cancer plans, policy-making bodies seemed to 
have gradually transformed a human right, as it is for psychosocial care, to a luxury not 
constituting an essential component of care. These findings confirm what reported by a recent 
European study that, although it did not take into account if POS were or not were active [18], 
showed that only 30% reported as having nationally recommended psychosocial oncology 
care clinical guidelines, and 37% as having specific budgets for these guidelines. Significant 
disparities were  also reported in the only two psycho-oncology societies in Africa, one of 
which is formalized as a POS and the other which is in the process.  
Several challenges and problems were identified by the participating POS in this survey, again 
these varied according to local circumstances. A number of POS identified the paucity of 
funding for clinical care as a major problem. Governments and insurers almost everywhere 
are attempting to reduce health care expenditures using austerity policies, economic 
exigencies and privatization to justify this, in some cases for purely ideological reasons. These 
factors have seemingly limited the growth and development of psycho-oncology care for 
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cancer patients or reduced their capacity were they exist. Where disposable incomes are 
limited and out-of-pocket or co-payment is required, many patients are unwilling to seek or 
cannot afford professional help that does not directly serve curative functions. There has also 
been an overall decline in research funding awarded to psycho-oncology, with only small, 
often declining percentage of the budgets of cancer societies or national programs allocated to 
psychosocial oncology research. One POS cited the need for stronger research evidence to 
clarify the benefits of some psycho-oncology interventions in cost-effectiveness terms as well 
as outcomes (e.g. 21), something that will prove increasingly difficult with financial 
restrictions.  
On these figures, in the future of the IPOS Federation new significant obligations should be 
added in its mission, as repeatedly stressed elsewhere [22,23,24]. It is necessary to help those 
countries which, although active within their national POS, are still not able to liaise with 
governmental institutions in order to have psychosocial oncology standards of care in national 
cancer plans. Also, besides creating opportunities for training and the provision of support in 
drafting and implementation of POS where they do not exist, it seems to be mandatory the 
development of more effective policies.  The role of IPOS and other organization supporting 
IPOS, such as the World Health Organization (WHO) and the Union for International 
Cancer Control (UICC), should be considered strategic in this. The WHO for example has 
strongly supported palliative care as a fundamental area to health and a basic human right, by 
clearly and unambiguously recognizing the obligation of all countries to make sure no one 
needlessly suffers from pain and other debilitating symptoms [25,26]. It is mandatory to apply 
and to extend these aims to whole trajectory of cancer care, where debilitating symptoms, 
including psychosocial distress and the manifold forms of spiritual suffering and mental 
disorders should be also recognized as a human right [23, 27]. This could be partnered with 
what the United Nations High Commissioner for Human Rights and the WHO Human Right 
declaration on mental health states, that “there is a right to be treated with dignity as a human 
being, that there is the right of everyone to enjoy the highest attainable standard of physical 
and mental health and the right to have access to psychosocial services and psychosocial 
intervention in the event of sickness.” [28] A WHO Resource Book on Mental Health, Human 
Rights and Legislation and a number of tools (e.g. checklist, training exercises) have been 
developed, in order to assist countries in reviewing and assessing the comprehensiveness and 
adequacy of their existing law, to increase people's skills in the area of mental health, human 
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rights and legislation and to help them in the process of drafting new laws, when necessary. 
[29,30,31]. These strategies could be extended to psycho-oncology, moving forward from 
declaration to action in a more structured way. Similar arguments can be done with respect to 
the Union for International Cancer Control (UICC) that has endorsed the IPOS Standards 
and recognizing Distress as the 6th Vital Sign; added a specific aim (Target 8) of effective 
pain control and distress management services to be universally available (UICC  World 
Cancer Declaration 2013); and claimed that it is necessary to promote and support national 
capacity in order to “increase investment in basic, clinical and implementation research 
across fields and disciplines including psycho-oncology, behavioural medicine and 
survivorship, and make specific efforts to accelerate the translation of research findings into 
clinical practice” [32]. Finally, it is increasingly incumbent on POS to challenge the 
prevailing political discourse of neoliberal rhetoric that is used so often to justify cuts to 
health services funding and care provision.  All to often this is more ideological than it is 
economic necessity. Advocacy for sustaining and improving care needs to be part of the POS 
skills set.  
However, if this can be important as at an international level, more effort is needed at national 
level. Without strong coalitions with oncology societies, better national research initiatives, 
cancer plans and patient advocacy movements, it is difficult that initiatives planned just at an 
international level can have an impact on national governments, with the risk of leaving the 
situation of psycho-oncology fragmented in many countries.  For example, the European 
Union Council Conclusions on reducing the burden of cancer [33] has produced in 2008 a 
document that was signed by the 27 EU Member-States recognizing the important role of 
psychosocial oncology in cancer stating that ‘to attain optimal results, a patient-centred 
comprehensive interdisciplinary approach and optimal psychosocial care should be 
implemented in routine cancer care, rehabilitation and post-treatment follow-up for all 
cancers’ (par. 5), with an open invitation to all EU member states ‘to take into account the 
psychosocial needs of patients and improve the quality of life for cancer patients through 
support, rehabilitation and palliative care’ (par.19). From our results, however, it seems that 
these indications have not been respected in the same way in the single countries,  and that, in 
spite of the efforts of the national POS, many countries in Europe are struggling with 
significant problems.   
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There are significant limitations in this survey. Because of its descriptive nature, more 
specific information about the single characteristic of psychosocial oncology in the single 
countries and more sophisticated statistical analysis are not allowed. Also the participating 
societies of the Federation reached an agreement in creating a general questionnaire, while 
more questions and topics could have been better operationalized by using a more structured 
(e.g. Likert-scales) questionnaire. This has been considered, however, as a further step for the 
future. The results reported are also based on information provided by the country POS 
referents and whilst we have endeavoured to be accurate in the description derived from the 
survey, possible inaccuracies may be present. Also, changes can be determined in the last 
years after the survey was conducted.  
In conclusion, although the survey contains non-negligible limitations, the results depict some 
important aspects on current status of psycho-social service in countries around the world 
where established POS exist. Likewise what described in several papers relative to cancer 
care in general (e.g. access to public health and medical services, shortages of specialist staff, 
increased demand for services and lack of knowledge about cancer patients’ problems) 
[34,35,36,37,38], the data regarding psychosocial care indicate the need to work more closely 
together at national and international levels to defend and to make mandatory a true patient-
centred comprehensive interdisciplinary approach and optimal and routine psychosocial care 
in cancer settings. 
 
 
Acknowledgements: All the members of the single POS are acknowledged for their contribution to 
the development of psycho-oncology and their commitment.  
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Legenda: Psycho-oncology societies, currently (2015) members of the IPOS Federation, by areas of the world: Africa: 
Psycho-oncology Society of Nigeria (POSON); North America: American Psychosocial Oncology Society (APOS), Canadian 
Association of Psychosocial Oncology (CAPO).  South America: Brazilian Psycho-Oncology Society (SBPO). Europe: Austrian 
Platform of Psycho-oncology (ÖPPO), British Psychosocial Oncology Society (BPOS), Bulgarian Society of Psycho-Oncology 
(BAPO)*, Dutch Society of Psychosocial Oncology (NVPO), French Society of Psycho-Oncology (SFPO) , German Association 
of Psycho-Social Oncology (DAPO) , Hellenic Society of Psychosocial Oncology (HSPO, Greece) , Hungarian Psycho-
Oncology Society (MPOT) ; Italian Society of Psycho-Oncology (SIPO), Lithuania Association of Psychosocial Oncology (POA, 
Lithuania), Polish Psycho-oncology Society (PPOS), Portuguese Academy of Psycho-Oncology (APPO), Portuguese Psycho-
Oncology Society (SPPO) , Romanian Association of Psycho-Oncology (ARPO) , Slovenian Society of Psycho-Oncology; 
Spanish Psycho-Oncology Society (SEPO) , Swedish Psycho-Oncology Society (SWEDPOS), Swiss Society of Psycho-Oncology 
(SGPO). East Asia: Chinese Psycho-Oncology Society (CPOS), Japan Psycho-Oncology Society (JPOS) , Korean Society Psycho-
Oncology,  Taiwanese Psycho-Oncology Society (TPOS). Australia/New Zealand: Australian Psychosocial Oncology Society 
(OZPOS)  and Psycho-oncology Co-operative Research Group (PoCoG, Australia) , Psycho-Social Oncology New Zealand 
(PONZ). Middle East: Israel Psycho-Oncology Society (IPSO); Turkish Psychosocial Oncology Association (PSOD) 
* The Bulgarian Society of Psycho-Oncology became part of the  Federation in 2015. There are also countries that have 
societies in a developing phase, including the Irish Society of Psycho-Oncology, the Russian Society of Psycho-Oncology, the 
Psycho-Oncology Society in Kenya and the society of Psycho-Oncology in South Africa, where, at the moment, the South 
African Oncology Social Work Association (SAOSWA)   
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Table 1. Federated  Psycho-Oncology societies and main characteristics  
 
Area of the 
world and 
country 
Year of foundation  
and website 
N. 
members  
Support 
from the 
governm
ent 
Link with 
academic 
institutions 
Link with 
other 
professional 
societies  
(e.g. nursing, 
oncology, 
palliative care) 
Coverage 
of PO by 
NHS or 
insurance 
Level of 
developme
nt of PO in 
the 
country  
(see appendix 
for legenda 
Africa        
Nigeria 2009 
www.posononline.com 
100 N Y N  3a 
Asia        
China 2006 425 Y Y Y Y 3b 
Japan 1986 
http://www.jpos-
society.org/ 
1683 Y N Y Y 4b 
Korea 2005 80 N N N N 3a 
Taiwan  2009 
www.tpos-society.org/ 
167 Y Y Y Y 4a 
Australia        
Australia 2005 
www.pocog.org.au 
1240 Y Y Y Y 4b 
New 
Zealand 
2001 
www.ponz.org.nz 
35 Y Y N N 3b 
Europe        
Austria 2003 
www.oeppo.com 
80 N Y Y Y 4a 
France 1982 
www.sfpo.fr 
100 N N Y Y 4a 
Germany 1983 
www.dapo-ev.de 
529 Y Y Y NR 4b 
Italy 1985 
www.siponazionale.it 
732 N Y Y Y 4a 
Lithuania 2007 
www.POA.lt 
40 N Y Y Y/N 3b 
Netherlands 1993 
www.nvpo.nl 
450 N Y Y Y 4a 
Poland 1993 
www.ptpo.org.pl 
200 Y -- Y Y 4a 
Portugal 1995 
 
1999 
www.appo.pt 
71 
 
 
100 
N 
 
 
N 
Y 
 
 
N 
Y 
 
 
N 
Y 3b/4a 
Romania 2002 
www.arpo.org   
80 N Y Y Y/N 3a 
Slovenia 2011 15 Y Y Y Y 3a 
Spain 2002 
www.sepo.es   
100 N N N  3a 
Sweden 2007 
www.swedpos.se 
130 N N Y Y 3b 
Switzerland 2003 
www.psychoonkologie.c
220 N Y Y Y 4a 
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h 
UK 1983 
http://www.bpos.org 
60 N N N Y 4a 
        
Middle East        
Israel 1992 170 N Y Y  4a 
North 
America 
       
Canada 1987 
www.capo.ca 
300 Y Y N Y 4a 
USA 1986 
www.apos-society.org 
450 Y Y Y Y/N 4a 
South 
America 
       
Brazil 1994 
www.sbpo.org.br 
330 N N Y Y 3a 
        
Legenda:  Y=Yes; N=No; Y/N, not completely covered by the national health system or partially covered; NR=Not 
reported 
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Fig. 2. Roles and professions of the members of the 25 POS  of the Federation 
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Table 2. Main problems to cope with as reported by the Federated POS  
 
1. Lack of resources and funding (including no government support) 
2. Problems with the national health care system (e.g. PO either not taken into account 
in National Cancer Plans, or when part of NCP, but not considered within the 
specialties that are part the Essential Level of Care) 
3. Difficult Implementation of national homogenous guidelines in the area of psycho-
oncology 
4. PO not recognized as a speciality (ministerial level)  
5. Lack of psychosocial oncology services for cancer patients and families in small towns 
or rural and remote areas (psycho-oncology mostly active in highly specialized cancer 
centers or university centers) 
6. Problems of dissemination of psycho-oncology in a multi-ethnic and multi-cultural 
country with some ethnic minorities have their own language and culture   
7. Small number of mental health professionals (e.g. psychologists, psychiatrists)  
trained in psycho-oncology and no contract for them within the health care system 
8. Stigma about mental health issues 
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Appendix 1. Summary of the main area investigated by the questionnaire 
 
A) Society information  
 Name of the society:       
 Year of foundation:        
 Number of Members regularly registered (approximately):     
 Society Website URL (if existent):       
 Name of the current President:   (appointed year:            -          )   
 Is there a regular conference? – how often? :      
 What are the existing communication methods among members? (check what applies) 
□ Journal (Please provide name and website link:     ) 
□  Newsletter 
□ Email list 
□ Social network service (e.g. Facebook)  (specify:    ) 
□ Others (specify:    ) 
 
 Composition of members of your society  
1) Advanced practice nurse: % 
2) Registered nurse : % 
3) Patients and family :  % 
4) Physician (other than psychiatrist):  % 
5) Psychiatrist  :  % 
6) Psychologist  :  % 
7) Social worker  :  % 
8) Others (please specify)  :  %  (    ) 
    Others (please specify)  :  %  (    ) 
 
B) Society information 
Organization 
1. Committees / Subgroups (Please list all committees, special interest groups, and other subgroups of the society; e.g. 
executive board, publication committee, pediatric workgroup, etc...) 
2. Is there any support from (or link to) the government? If yes, please describe. 
Yes / No 
3. Is there any link to academic institutions? If yes, please describe. 
Yes / No 
4. Is there any partnership with other professional societies (e.g. nursing, oncology, palliative care... )? If yes, please 
describe. 
Yes / No 
5. Please describe if there is any other information (characteristics of your society) you want to add. 
 
Activities 
1. Please list a few major ongoing projects / activities of the society 
2. What are the facing problems / challenges of the society? 
3. Are there any internationally collaborative projects? 
4. Is your society willing to mentor, to be mentored, or to be partnered with other federation societies? If so, please 
describe possible area of collaboration. 
5. Is there anything your society wants IPOS or IPOS Federation to do to help promoting the activities of your society? 
Health care information 
Describe if there is any characteristic of your community (health care system, culture, etc.) that may influence (benefit or 
impede) psycho-social care of cancer patients? (e.g. National universal health insurance coverage, lack of resources, etc) 
Please include comments on whether psycho-oncology care is reimbursed (covered) in your health-care system. 
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Situation of Psycho-social oncology in the country 
Please circle the level (number) that best describes the situation of psychosocial oncology in your country. 
 
Level Description 
1 No known psycho-social oncology care activity 
Unable to identify any psycho-social care activity in the country, although there may be chances that current 
work has been unrecognized. 
2 Capacity building activity 
There is evidence of wide-ranging initiatives designed to create the organizational, workforce and policy capacity 
for psychosocial oncology care services to develop, though no service has yet been established. The 
developmental activities include: attendance at, or organization of, key conferences; personnel undertaking 
external training in psycho-social oncology care; lobbying of policy-makers and ministries of health; and incipient 
service development. 
3a Isolated care provision 
The country is characterized by: the development of psychosocial oncology care activism that is patchy in scope 
and not well supported; sourcing of funding that is often heavily donor-dependent; limited availability of care. 
3b Generalized care provision 
The countries is characterized by: the development of psychosocial oncology care activism in a number of 
locations with the growth of local support in those areas; multiple sources of funding; the availability of care; a 
number of psychosocial oncology care services from a community of providers that are independent of the 
healthcare system; and the provision of some training and education initiatives. 
4a Preliminary integration into mainstream service provision 
The countries is characterized by: the development of a critical mass of psychosocial oncology care activism in a 
number of locations; a variety of psychosocial oncology care providers and types of services; awareness on the 
part of health professionals and local communities; the availability of psychosocial oncology service; limited 
impact of psychosocial oncology service care upon policy; the provision of a substantial number of training and 
education initiatives by a range of organizations. 
4b Advanced integration into mainstream service provision 
The country is characterized by: the development of a critical mass of psychosocial oncology care activism in a 
wide range of locations; comprehensive provision of care by multiple service providers; broad awareness of 
psychosocial oncology care on the part of health professionals, local communities and society in general; 
unrestricted availability of multiple aspects of psychosocial oncology care; substantial impact of psychosocial 
oncology care upon policy, in particular upon public health policy; the development of recognized education 
centers; academic links forged with universities. 
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Appendix 2. 
The paper has been co-authored by all the members that participated in the survey as 
referents/presidents of the national POS, namely 
Judith Alder (judithalder1@gmail.com), Switzerland  
Elisabeth Andtritsch (Elisabeth.Andritsch@klinikum-graz.at), Austria  
Antonio Barbosa (abarbosa@netcabo.pt), Portugal 
Joan Bottorff (joan.bottorff@ubc.ca ),  Canada 
Giedre Bulotiene (giedre.bulotiene@vuoi.lt), Lithuania 
Phillys Butow (phyllisb@psych.usyd.edu.au), Australia 
Miri Cohen (mcohen2@univ.haifa.ac.il), Israel 
Anna Costantini (annacostantini@alice.it), Italy 
Sara Dauchy (Sarah.DAUCHY@gustaveroussy.fr), France  
Csaba L. Dégi (csabadegi@gmail.com), Romania 
Jurama Ribeiro de Oliveira (presidente@sbpo.org.br), Brazil 
Krystyna de Walden-Galuszko (galuszko@ptpo.org.pl), Poland  
Haryana Dhillon (haryana.dhillon@sydney.edu.au),  Australia 
Chun-Kai Fang (chunkai.fang0415@gmail.com ),  Taiwan  
Michelle Cororve Fingeret (MCFinger@mdanderson.org), USA 
Francisco Luis Gil (fgil@iconcologia.net), Spain 
Patrik Göransson (ordforande@swedpos.se),  Sweden  
Josette Hoekstra Weebers (.Hoekstra@iknl.nl), The Netherlands   
Clare Louise Manicom (Clare.Manicom@cancercare.co.za ), South Africa  
Deborah McLeod (DeborahL.McLeod@cdha.nshealth.ca ), Canada 
Lúcia M. Silva Monteiro (lmonteiro@ipolisboa.min-saude.pt),  Portugal 
Jong-Heun Kim (psy@ncc.re.kr), Korea  
Hazel Neser, (hazel.neser@otago.ac.nz), New Zealand  
Eisuke Matsushima (em.lppm@tmd.ac.jp),  Japan  
William F. Pirl (WPIRL@PARTNERS.ORG), USA  
Melanie Price (melanie.price@sydney.edu.au), Australia  
Laura Monica Radu (ml2radu@yahoo.com),  Romania 
Thomas Schopperth, (tschopperth@krebsgesellschaft-rlp.de), Germany 
Andrea Schumacher (Andrea.Schumacher@ukmuenster.de), Germany 
Anja Simonič (anja.simonic@klinika-golnik.si ),  Slovenia  
Lili Tang (tanglili2005@hotmail.com), China 
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